Investors

Insider Transactions

Date Sorted Descending Name Title Type Shares Traded Price Range
Jul 2, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 212,400 298.91 - 311.92
Jul 1, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 212,400 285.89 - 304.01
Jul 1, 2014 vagelos p roy Officer Disposition (Non Open Market) 756 n/a
Jun 30, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 212,400 275.68 - 284.53
Jun 27, 2014 sanofi Beneficial Owner (10% or more) Automatic Buy 50,000 272.70 - 277.43
May 23, 2014 van plew daniel p Officer Sell 5,369 295.33 - 296.70
May 22, 2014 van plew daniel p Officer Disposition (Non Open Market) 5,831 296.19
May 22, 2014 van plew daniel p Officer Option Execute 11,200 21.25
May 21, 2014 poon christine a Director Buy 255 291.90
May 19, 2014 sanofi Beneficial Owner (10% or more) Buy 190,751 296.08 - 302.70
Apr 1, 2014 vagelos p roy Officer Disposition (Non Open Market) 700 n/a
Mar 28, 2014 sanofi Beneficial Owner (10% or more) Buy 306,945 300.28 - 315.33
Mar 27, 2014 sanofi Beneficial Owner (10% or more) Buy 306,945 302.96 - 316.49
Mar 25, 2014 goldstein joseph l Director Acquisition (Non Open Market) 10,000 n/a
Mar 24, 2014 baker charles a Director Automatic Sell 15,000 300.09 - 313.40
Mar 24, 2014 baker charles a Director Option Execute 15,000 23.84
Mar 24, 2014 sanofi Beneficial Owner (10% or more) Buy 306,945 299.01 - 314.22
Mar 21, 2014 sanofi Beneficial Owner (10% or more) Buy 305,115 313.12 - 332.78
Mar 20, 2014 sanofi Beneficial Owner (10% or more) Buy 57,957 325.94 - 328.93
Mar 19, 2014 sanofi Beneficial Owner (10% or more) Buy 9,746 326.44 - 328.67
Showing 101-120 of 887 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)